Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
8.10    0.06 (0.75%)
Bid:
7.90
Ask:
8.30
Spread: 0.40 (5.063%)
Market Cap: £39.85m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

DFS Performance Shares - Replacement

7 Jan 2026 09:17

RNS Number : 9854N
Blencowe Resources PLC
07 January 2026
 

7 January 2026

This is a replacement to RNS 1504N dated 30 December 2025. The date of admission has changed to 12 January 2026 and the total voting rights is now 477,295,645 following admission of the DFS Performance Shares.

 

Blencowe Resources Plc

("Blencowe" or the "Company")

 

Issue of DFS Performance Shares

 

Blencowe Resources Plc (LSE: BRES) announces that it has issued 12,000,000 DFS Performance Shares.

The DFS Performance Options have now vested following the completion and publication of the company's Definitive feasibility Study on 1 December 2025. Accordingly, the Company is now required to issue 12,000,000 new ordinary shares as set out below (the "DFS Performance Shares").

Each holder of the DFS Performance Shares has agreed to a lock up for a period of 12 months from Admission.

Director

DFS Performance shares issued

Current holdings

Holdings on Admission

Holdings % of Enlarged Share Capital

Cameron Pearce

3,000,000

13,016,667

16,016,667

3.4%

Mike Ralston

3,000,000

10,891,666

13,891,666

2.9%

Iain Wearing

3,000,000

10,461,666

13,461,666

2.8%

Lionshead Consultants Ltd *

2,250,000

7,833,334

10,083,334

2.1%

Alex Passmore

750,000

2,816,667

3,566,667

0.7%

* beneficially owned by Sam Quinn

Admission and Total Voting Rights

An application has been made for 12,000,000 Ordinary Shares to be admitted to trading on the Equity (Transition) category of the official list and the main market of the London Stock Exchange from 8.00 a.m. on 12 January 2026 ("Admission").

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company confirms that following Admission, the Company's enlarged issued ordinary share capital will comprise 477,295,645 Ordinary Shares. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the above figure may be used by shareholders in the Company as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Blencowe Resources Plc

Sam Quinn

 

www.blencoweresourcesplc.com

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Investor Relations

Sasha Sethi

Tel: +44 (0) 7891 677 441

sasha@flowcomms.com

 

Tavira Financial 

Jonathan Evans

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

 

 

Twitter https://twitter.com/BlencoweRes

LinkedIn https://www.linkedin.com/company/72382491/admin/

 

 

 

 

Appendix

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

(This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 

1. Cameron Pearce

2. Mike Ralston

3. Iain Wearing

4. Lionshead Consultants (S Quinn)

5. Alexander Passmore

 

 

2

Reason for the notification

a)

Position/status

1. Director

2. Manager

3. Manager

4. Director

5. Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Blencowe Resources PLC

b)

LEI

 

213800UX1HBIRK36GG11

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares

 

 

 

GB00BFCMVS34

b)

Nature of the transaction

Exercise of Share options

c)

Price(s) and volume(s)

Price

Volume

1. 0.005

2. 0.005

3. 0.005

4. 0.005

5. 0.005

1. 3,000,000

2. 3,000,000

3. 3,000,000

4. 2,250,000

5. 750,000

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

£0.005

e)

Date of Transaction

 

 30 December 2025

f)

Place of transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDBSGGDGLR
Date   Source Headline
16th Dec 20217:00 amRNSGraphite Sales and Marketing Expert Appointed
10th Dec 20213:35 pmRNSPublication of a Prospectus
8th Dec 202110:11 amRNSResult of General Meeting
8th Dec 20218:28 amRNSWebinar Call
15th Nov 202111:56 amRNSAMENDED Notice of General Meeting
15th Nov 202111:37 amRNSNotice of GM
12th Nov 20218:33 amRNSOver-Subscribed £2m Capital Raise
4th Oct 20217:00 amRNSCorporate Presentation
29th Sep 20217:00 amRNSOrom Cross PEA
20th Sep 20217:00 amRNSOrom Cross Update
17th Sep 20219:19 amRNSTR-1: Standard form notification of major holdings
16th Aug 20217:00 amRNSSecond Drilling Program at Orom-Cross Project
20th Jul 20212:01 pmRNSInvitation to Webinar
14th Jul 20217:00 amRNSIssue of Equity
13th Jul 20217:34 amRNSResults of Metallurgical Test Work
5th Jul 20217:00 amRNSDrill Program Ahead of Schedule
24th Jun 20214:00 pmRNSTR-1: Standard form notification of major holdings
2nd Jun 20219:54 amRNSHalf-year Report
1st Jun 20217:00 amRNSTR-1: Standard form notification of major holdings
24th May 20217:00 amRNSMetallurgical Test Work
19th May 202111:34 amRNSUpdated Corporate Presentation
14th May 202112:00 pmRNSTransaction in Shares
4th May 20217:00 amRNSStage Two Drilling Program Commences
29th Apr 20212:12 pmRNSDirector/PDMR Shareholding
26th Apr 20211:26 pmRNSHolding(s) in Company
13th Apr 20217:30 amRNSInvestor Webinar
13th Apr 20217:00 amRNSMaiden JORC Mineral Resource
7th Apr 20212:30 pmRNSWarrant Exercise
31st Mar 202110:08 amRNSResult of AGM
24th Mar 202111:30 amRNSWarrant Exercise
8th Mar 20214:30 pmRNSNotice of AGM
1st Mar 20217:00 amRNSDrilling Results
12th Feb 20217:00 amRNSTR-1: Standard form notification of major holdings
8th Feb 20212:12 pmRNSWarrant Exercise
8th Feb 20217:07 amRNSDrilling Results at Camp Lode
26th Jan 20217:00 amRNSAnnual Financial Report
22nd Jan 20211:07 pmRNSInvestor Conference Call
18th Jan 20217:00 amRNSPlacing to Raise £500,000
16th Dec 20207:00 amRNSPlacing to Raise £300,000
9th Dec 20209:52 amRNSTR-1: Standard form notification of major holdings
1st Dec 202011:01 amRNSBlock Listing Application Update
27th Nov 202012:11 pmRNSBlock Listing Application Update
26th Nov 20207:16 amRNSJORC Resource Update
25th Nov 20201:59 pmRNSBlock Listing Application & Issue of Equity
23rd Nov 20207:00 amRNSDirector Warrant Exercise and Purchase of Shares
5th Nov 20207:00 amRNSPublication of New Research Note
14th Oct 20202:07 pmRNSHolding(s) in Company
14th Oct 20207:21 amRNSHolding(s) in Company
14th Oct 20207:20 amRNSHolding(s) in Company
13th Oct 202010:21 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.